Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Insights and Forecast to 2028

Report ID: 1750081 | Published Date: Jan 2025 | No. of Page: 88 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 PCR
        1.2.3 In-situ Hybridization
        1.2.4 Immunohistochemistry
        1.2.5 Sequencing
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Oncology
        1.3.3 Neurological Disorders
        1.3.4 Cardiovascular Disease
        1.3.5 Immunological Disorders
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Perspective (2017-2028)
    2.2 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Growth Trends by Region
        2.2.1 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Historic Market Size by Region (2017-2022)
        2.2.3 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Forecasted Market Size by Region (2023-2028)
    2.3 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Dynamics
        2.3.1 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Industry Trends
        2.3.2 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Drivers
        2.3.3 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Challenges
        2.3.4 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Players by Revenue
        3.1.1 Global Top Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Players by Revenue (2017-2022)
        3.1.2 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Market Share by Players (2017-2022)
    3.2 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue
    3.4 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Concentration Ratio
        3.4.1 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue in 2021
    3.5 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Key Players Head office and Area Served
    3.6 Key Players Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product Solution and Service
    3.7 Date of Enter into Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Breakdown Data by Type
    4.1 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Historic Market Size by Type (2017-2022)
    4.2 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Forecasted Market Size by Type (2023-2028)
5 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Breakdown Data by Application
    5.1 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Historic Market Size by Application (2017-2022)
    5.2 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size (2017-2028)
    6.2 North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type
        6.2.1 North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2022)
        6.2.2 North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2023-2028)
        6.2.3 North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Type (2017-2028)
    6.3 North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application
        6.3.1 North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2022)
        6.3.2 North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2023-2028)
        6.3.3 North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Application (2017-2028)
    6.4 North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country
        6.4.1 North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2017-2022)
        6.4.2 North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size (2017-2028)
    7.2 Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type
        7.2.1 Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2022)
        7.2.2 Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2023-2028)
        7.2.3 Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Type (2017-2028)
    7.3 Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application
        7.3.1 Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2022)
        7.3.2 Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2023-2028)
        7.3.3 Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Application (2017-2028)
    7.4 Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country
        7.4.1 Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2017-2022)
        7.4.2 Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size (2017-2028)
    8.2 Asia-Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type
        8.2.1 Asia-Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Type (2017-2028)
    8.3 Asia-Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application
        8.3.1 Asia-Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Application (2017-2028)
    8.4 Asia-Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Region
        8.4.1 Asia-Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size (2017-2028)
    9.2 Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type
        9.2.1 Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2022)
        9.2.2 Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2023-2028)
        9.2.3 Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Type (2017-2028)
    9.3 Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application
        9.3.1 Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2022)
        9.3.2 Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2023-2028)
        9.3.3 Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Application (2017-2028)
    9.4 Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country
        9.4.1 Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2017-2022)
        9.4.2 Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size (2017-2028)
    10.2 Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type
        10.2.1 Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Type (2017-2028)
    10.3 Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application
        10.3.1 Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Application (2017-2028)
    10.4 Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country
        10.4.1 Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Qiagen NV
        11.1.1 Qiagen NV Company Details
        11.1.2 Qiagen NV Business Overview
        11.1.3 Qiagen NV Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Introduction
        11.1.4 Qiagen NV Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
        11.1.5 Qiagen NV Recent Developments
    11.2 GE Healthcare
        11.2.1 GE Healthcare Company Details
        11.2.2 GE Healthcare Business Overview
        11.2.3 GE Healthcare Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Introduction
        11.2.4 GE Healthcare Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
        11.2.5 GE Healthcare Recent Developments
    11.3 Agilent Technologies
        11.3.1 Agilent Technologies Company Details
        11.3.2 Agilent Technologies Business Overview
        11.3.3 Agilent Technologies Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Introduction
        11.3.4 Agilent Technologies Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
        11.3.5 Agilent Technologies Recent Developments
    11.4 F Hoffman La Roche
        11.4.1 F Hoffman La Roche Company Details
        11.4.2 F Hoffman La Roche Business Overview
        11.4.3 F Hoffman La Roche Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Introduction
        11.4.4 F Hoffman La Roche Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
        11.4.5 F Hoffman La Roche Recent Developments
    11.5 Foundation Medicine
        11.5.1 Foundation Medicine Company Details
        11.5.2 Foundation Medicine Business Overview
        11.5.3 Foundation Medicine Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Introduction
        11.5.4 Foundation Medicine Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
        11.5.5 Foundation Medicine Recent Developments
    11.6 Thermo Fisher Scientific Inc.
        11.6.1 Thermo Fisher Scientific Inc. Company Details
        11.6.2 Thermo Fisher Scientific Inc. Business Overview
        11.6.3 Thermo Fisher Scientific Inc. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Introduction
        11.6.4 Thermo Fisher Scientific Inc. Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
        11.6.5 Thermo Fisher Scientific Inc. Recent Developments
    11.7 Leica Biosystems Nussloch GmBH
        11.7.1 Leica Biosystems Nussloch GmBH Company Details
        11.7.2 Leica Biosystems Nussloch GmBH Business Overview
        11.7.3 Leica Biosystems Nussloch GmBH Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Introduction
        11.7.4 Leica Biosystems Nussloch GmBH Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
        11.7.5 Leica Biosystems Nussloch GmBH Recent Developments
    11.8 Pfizer
        11.8.1 Pfizer Company Details
        11.8.2 Pfizer Business Overview
        11.8.3 Pfizer Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Introduction
        11.8.4 Pfizer Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
        11.8.5 Pfizer Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of PCR
    Table 3. Key Players of In-situ Hybridization
    Table 4. Key Players of Immunohistochemistry
    Table 5. Key Players of Sequencing
    Table 6. Key Players of Others
    Table 7. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 8. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Region (2017-2022)
    Table 11. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Region (2023-2028)
    Table 13. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Trends
    Table 14. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Drivers
    Table 15. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Challenges
    Table 16. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Restraints
    Table 17. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Share by Players (2017-2022)
    Table 19. Global Top Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) as of 2021)
    Table 20. Ranking of Global Top Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product Solution and Service
    Table 24. Date of Enter into Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Market Share by Type (2017-2022)
    Table 28. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Market Share by Type (2023-2028)
    Table 30. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Share by Application (2017-2022)
    Table 32. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue Share by Application (2023-2028)
    Table 34. North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2022) & (US$ Million)
    Table 35. North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2023-2028) & (US$ Million)
    Table 36. North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2022) & (US$ Million)
    Table 37. North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2023-2028) & (US$ Million)
    Table 38. North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2017-2022) & (US$ Million)
    Table 39. North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2022) & (US$ Million)
    Table 41. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2023-2028) & (US$ Million)
    Table 42. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2022) & (US$ Million)
    Table 43. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2023-2028) & (US$ Million)
    Table 44. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2017-2022) & (US$ Million)
    Table 45. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2023-2028) & (US$ Million)
    Table 50. Asia Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Region (2017-2022) & (US$ Million)
    Table 51. Asia Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Region (2023-2028) & (US$ Million)
    Table 52. Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2022) & (US$ Million)
    Table 53. Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2023-2028) & (US$ Million)
    Table 54. Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2022) & (US$ Million)
    Table 55. Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2023-2028) & (US$ Million)
    Table 56. Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2017-2022) & (US$ Million)
    Table 57. Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Country (2023-2028) & (US$ Million)
    Table 64. Qiagen NV Company Details
    Table 65. Qiagen NV Business Overview
    Table 66. Qiagen NV Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product
    Table 67. Qiagen NV Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million)
    Table 68. Qiagen NV Recent Developments
    Table 69. GE Healthcare Company Details
    Table 70. GE Healthcare Business Overview
    Table 71. GE Healthcare Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product
    Table 72. GE Healthcare Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million)
    Table 73. GE Healthcare Recent Developments
    Table 74. Agilent Technologies Company Details
    Table 75. Agilent Technologies Business Overview
    Table 76. Agilent Technologies Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product
    Table 77. Agilent Technologies Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million)
    Table 78. Agilent Technologies Recent Developments
    Table 79. F Hoffman La Roche Company Details
    Table 80. F Hoffman La Roche Business Overview
    Table 81. F Hoffman La Roche Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product
    Table 82. F Hoffman La Roche Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million)
    Table 83. F Hoffman La Roche Recent Developments
    Table 84. Foundation Medicine Company Details
    Table 85. Foundation Medicine Business Overview
    Table 86. Foundation Medicine Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product
    Table 87. Foundation Medicine Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million)
    Table 88. Foundation Medicine Recent Developments
    Table 89. Thermo Fisher Scientific Inc. Company Details
    Table 90. Thermo Fisher Scientific Inc. Business Overview
    Table 91. Thermo Fisher Scientific Inc. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product
    Table 92. Thermo Fisher Scientific Inc. Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million)
    Table 93. Thermo Fisher Scientific Inc. Recent Developments
    Table 94. Leica Biosystems Nussloch GmBH Company Details
    Table 95. Leica Biosystems Nussloch GmBH Business Overview
    Table 96. Leica Biosystems Nussloch GmBH Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product
    Table 97. Leica Biosystems Nussloch GmBH Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million)
    Table 98. Leica Biosystems Nussloch GmBH Recent Developments
    Table 99. Pfizer Company Details
    Table 100. Pfizer Business Overview
    Table 101. Pfizer Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Product
    Table 102. Pfizer Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million)
    Table 103. Pfizer Recent Developments
    Table 104. Research Programs/Design for This Report
    Table 105. Key Data Information from Secondary Sources
    Table 106. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Type: 2021 VS 2028
    Figure 2. PCR Features
    Figure 3. In-situ Hybridization Features
    Figure 4. Immunohistochemistry Features
    Figure 5. Sequencing Features
    Figure 6. Others Features
    Figure 7. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Application: 2021 VS 2028
    Figure 8. Oncology Case Studies
    Figure 9. Neurological Disorders Case Studies
    Figure 10. Cardiovascular Disease Case Studies
    Figure 11. Immunological Disorders Case Studies
    Figure 12. Others Case Studies
    Figure 13. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Report Years Considered
    Figure 14. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 15. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Region: 2021 VS 2028
    Figure 17. Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Players in 2021
    Figure 18. Global Top Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) as of 2021)
    Figure 19. The Top 10 and 5 Players Market Share by Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue in 2021
    Figure 20. North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY (2017-2028) & (US$ Million)
    Figure 21. North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Type (2017-2028)
    Figure 22. North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Application (2017-2028)
    Figure 23. North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Share by Country (2017-2028)
    Figure 24. United States Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Canada Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY (2017-2028) & (US$ Million)
    Figure 27. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Type (2017-2028)
    Figure 28. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Application (2017-2028)
    Figure 29. Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Share by Country (2017-2028)
    Figure 30. Germany Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. France Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. U.K. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Italy Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Russia Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Nordic Countries Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY (2017-2028) & (US$ Million)
    Figure 37. Asia Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Type (2017-2028)
    Figure 38. Asia Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Application (2017-2028)
    Figure 39. Asia Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Share by Region (2017-2028)
    Figure 40. China Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Japan Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. South Korea Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Southeast Asia Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. India Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Australia Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 46. Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY (2017-2028) & (US$ Million)
    Figure 47. Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Type (2017-2028)
    Figure 48. Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Application (2017-2028)
    Figure 49. Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Share by Country (2017-2028)
    Figure 50. Mexico Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Brazil Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Middle East & Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY (2017-2028) & (US$ Million)
    Figure 53. Middle East and Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Type (2017-2028)
    Figure 54. Middle East and Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Market Share by Application (2017-2028)
    Figure 55. Middle East and Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size Share by Country (2017-2028)
    Figure 56. Turkey Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. Saudi Arabia Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. UAE Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 59. Qiagen NV Revenue Growth Rate in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
    Figure 60. GE Healthcare Revenue Growth Rate in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
    Figure 61. Agilent Technologies Revenue Growth Rate in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
    Figure 62. F Hoffman La Roche Revenue Growth Rate in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
    Figure 63. Foundation Medicine Revenue Growth Rate in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
    Figure 64. Thermo Fisher Scientific Inc. Revenue Growth Rate in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
    Figure 65. Leica Biosystems Nussloch GmBH Revenue Growth Rate in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
    Figure 66. Pfizer Revenue Growth Rate in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Qiagen NV
GE Healthcare
Agilent Technologies
F Hoffman La Roche
Foundation Medicine
Thermo Fisher Scientific Inc.
Leica Biosystems Nussloch GmBH
Pfizer
Frequently Asked Questions
Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Oral Care

Oral Care market is segmented by players, region (country), by Type and by Application. Players,  ... Read More